Introduction
Nicotine can produce analgesia in both smokers and non-smokers, (1) and specifically produces modest postoperative analgesia in non-smokers, (2-4) but apparently not in smokers. (5) Chronic exposure to nicotine among tobacco users may also affect pain perception. For example, patients with chronic pain disorders who use tobacco report greater pain intensity and functional impairment compared with those who do not use tobacco. (6) (7) (8) Regarding acute pain, several studies have suggested that smokers have greater postoperative pain (9) and increased postoperative opioid requirements (10-12) than nonsmokers. Creekmore et al. demonstrated that smokers undergoing coronary artery bypass graft surgery (CABG) required more postoperative opioids than nonsmokers (33% greater opioid requirements adjusted for body mass index). (11) Limitations of these studies (small sample sizes, heterogenous surgical populations, and others) precluded meaningful adjustment for variables such as age (13) (14) (15) and gender (16, 17) which are known to strongly influence postoperative pain. Thus, the association between smoking and higher postoperative opiate requirements is unclear. The objective of this study was to test the hypothesis that tobacco use status is independently associated with postoperative opioid requirements in patients undergoing CABG when important demographic variables such as age and gender are taken into account.
Materials and Methods
The Mayo Clinic Institutional Review Board approved this study. In accordance with Minnesota law, only patients that had provided preauthorization for the use of their medical record in research were included (>95% of Mayo patients). Using the Mayo Clinic Cardiac Surgical Registry, we identified all patients that underwent CABG surgery via a primary sternotomy and had an endoscopically harvested saphenous vein graft during the time period of January 1 st 2007 thru December 31 st 2007. This vein grafting procedure produces minimal incisional pain at the site of harvest. Exclusion criteria included lack of data regarding current self-reported smoking status (never, former, or current smoker), prolonged endotracheal intubation (more than 12 hours after skin closure), and cardiac re-operation or death within 48 hours of extubation. Because incisional pain from vessel donor sites could affect opioid requirements (18) (19) (20) (21) (22) Only one patient, a 68 year old male who was taking methadone 5 mg three times a day for chronic face pain, was administered methadone in the postoperative period, a single 5 mg oral dose. For this case methadone was converted to morphine equivalents using a 1:1 conversion ratio. Upon arrival to the intensive care unit, a fentanyl infusion was initiated at 0.5 mcg/kg/hr and continued until extubation. Following extubation, typically, patients were administered intravenous fentanyl via a patient-controlled analgesia device until they could tolerate oral opiate medications and then were usually administered either oxycodone or tramadol. Patients also received scheduled acetaminophen. Nursing staff regularly obtain pain scores from patients using a numeric rating pain scale from 0 -10, with 0 being no pain and 10 being maximal pain. The use of nicotine replacement or varenicline in the postoperative period was also noted. Analysis. Statistical analysis was conducted using JMP (version 7.0.1, SAS Institute Inc., Cary, NC). Clinical and demographic variables were compared between groups using Student's t-test continuous variables and the chi-square test (or Fisher's exact test) for categorical variables. Initial analyses were * One patient received a single 5 mg dose of methadone. This patient was a 68-year-old male that used methadone 5 mg three times a day for chronic face pain. We chose a 1:1 conversion in this instance. performed with patients categorized into three groups (current, past tobacco users, and never tobacco users). Because past tobacco users and never tobacco users had similar postoperative opiate requirements (see below), these two groups were combined for subsequent multivariate analysis. Analysis of covariance (ANCOVA) was conducted for post-operative opiate requirements using age, gender and tobacco use as covariates. Pain was considered to be severe if the numeric pain score provided by a patient was 7 or greater. (23, 24) The association between current tobacco use and the risk of experiencing an episode of severe pain was determined with logistic regression. A subsequent multivariate analysis logistic regression model for the development of severe pain was also constructed using age, gender and tobacco use as covariates. In all cases a P value of <0.05 was considered significant.
Results
Four hundred fourteen (414) patients underwent coronary artery bypass surgery and received an endoscopically harvested saphenous vein graft. In this cohort, 69 patients reported current use of tobacco products (within 30 days prior to the surgery). Fifty-eight of the tobacco users used cigarettes as their primary tobacco product, with the remaining using either chewing tobacco or cigars. Tobacco users were younger than non-users (61 ± 11 vs 71 ± 10 years, P < 0.001), but had similar gender distribution (78% and 76% male among users and non-users, respectively, P = 0.72). Of the nonusers, 138 reported never using tobacco products and 207 reported prior use. Of the former users, 90% reported not using tobacco products for greater than one year and 71% reported not using for greater than 10 years. There was no age difference between former and never users (70 ± 10 vs 70 ± 11 years, P = 0.71), but a greater proportion of former smokers were male (82% vs 67%, P = 0.003). The number of patients that also underwent a valvular procedure during CABG similar was similar between tobacco users and nonusers (28% vs 27%, P = 0.210). Cardiopulmonary bypass times were similar among tobacco users and nonusers (95 ± 34 vs 94 ± 32 minutes, P = 0.83).
There was no significant difference in the amount of intraoperative opioids given to the three groups (table 2) . Current tobacco users received more opioids than non-users in the first 48 hours after extubation (401 ± 284 mg OME vs 314 ± 240 mg OME, P = 0.009). There was a trend for former users to use more opioids than never users (table 2) , but this did not reach statistical significance. However, after adjustment for demographic differences (age and gender) in multivariable analysis, the association between current tobacco 
Discussion
The major finding of this study is that current tobacco users undergoing CABG surgery utilize more opioid analgesics in the first 48 hours following extubation than nonusers of tobacco. However, when adjusting for age and gender, tobacco use was not independently associated with differences in postoperative opioid use. A secondary finding of this study is that tobacco users are not at increased risk for the development of severe postoperative pain. Chronic exposure to nicotine and other tobacco constituents is associated with an increased prevalence of chronic painful conditions in many studies. (25, 26) Among those with chronic pain, smokers report greater pain intensity and functional impairment. (7, 8) Multiple mechanisms may explain this association, including changes in acetylcholine receptor distribution or function in response to chronic nicotine exposure. On the other hand, nicotine itself can produce analgesia when administered acutely, both in smokers and non smokers, so that the overall effects of tobacco use on pain sensitivity appears to be complex and multi-factorial. (1) Creekmore et al. found that patients undergoing CABG surgery demonstrated that smokers had a 23% greater opioid requirement in the first 48 postsurgical hours compared with a group of former and never smokers. (11) The magnitude of the increased opioid requirement was very similar to our findings (tobacco users used 22% more post-operative opioids than non-users In a general surgical population, smokers reported higher pain scores both before and after surgery but did not experience greater increases in pain postoperatively compared with nonsmokers, (9) although in this study pain was only a secondary endpoint, opioid consumption was not measured, and a wide range of surgical procedures was included. Thus, our study is not directly comparable, but we did not find that tobacco users were at increased risk of severe postoperative pain. Our study had several significant limitations, including all the inherent limitations of a retrospective study. It also relied on patient self-report of tobacco use. Although such reports are generally reliable (28) there is the possibility that some of the non-users were actually using tobacco. Intraoperative management of anesthesia, including opioid administration, was not standardized, although a standardized regimen is followed in our cardiac anesthesia practice, as reflected by similar use of intraoperative opioids among all groups. Postoperative pain management was not standardized which introduces potential practice management differences as a source of bias. Furthermore, 25 tobacco users received therapy for nicotine withdrawal (nicotine replacement and/or varenicline), although we did not find an association between these therapies and opioid use. We did not attempt to exclude patients that used sustained release or long acting opiate formulations prior to surgery because this information was not always available from chart review. Because opioid tolerance increases postoperative opiate requirements 15 , potential differences between groups could have introduced bias. Data on the quantity or duration of tobacco use was also not available, and it has been suggested that heavy smokers have higher postoperative opiate requirements. (10) We studied only one type of surgery, which is an experimental strength. However, these findings may not apply to other surgical procedures, including those examined in the prior studies reviewed. Finally, our institution is a major referral center and our results may not generalize to community based patients.
In conclusion, tobacco users undergoing CABG surgery receive more opioids postoperatively than non-users, but this is primarily a function of the interactions between tobacco use and other factors known to influence postoperative opioid requirements, specifically younger age and male gender. Studies of how tobacco use affects postoperative pain must adjust for other clinical variables that influence postoperative pain.
